Cetirizine Hydrochloride Tablet
Product Images NDC 72476-764

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 72476-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Retail Business Services,llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14 Count (300000538 R 00 Final)

This is a description of a medication that provides 24-hour relief to indoor and outdoor allergies symptoms such as sneezing, runny nose, itchy, watery eyes, and itchy throat or nose. The medication comes in a tablet form, and the box contains two seven-unit doses, amounting to 14 tablets. The text also advises to keep the product away from children and to read the instructions carefully. There are some warnings about possible side effects and precautions when using the medication. However, the scanned text is incomplete and contains several errors, making it difficult to provide an accurate and reliable description.*

FDA Label Image

30 Count (300000539 R 00 Final)

This appears to be a mix of product names, descriptions, and random text that is difficult to discern. It is not providing a clear description or message, so it is not available.*

FDA Label Image

70 Count (300000541 R 00 Final)

FDA Label Image

90 Count (300000543 R 00 Final)

FDA Label Image

120 Count (300000545 R 00 Final)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.